United Therapeutics Corporation (Nasdaq: UTHR ), a public benefit corporation, today announced that its TETON-1 study evaluating the use of nebulized Tyvaso for the treatment of i ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results